Washington An Indian-American doctor has discovered a possible strategy or treatment method to prevent fatal damage to the lungs and dysfunction of organs in the lungs of Kovid-19 patients.
Dr. Tirumala Devi Kanneganti, born in India and posted as a researcher at St. Jude Children’s Research Hospital in Tennessee, has been published in the online edition of the research journal ‘SAIL’. In this, during studies on mice, they found that in the case of Kovid-19, inflammation in the cells due to the dysfunction of the organs is ‘hyperinflammatory’ resistance, which ultimately leads to death and of the possible drugs to protect the condition. Identified.
The researcher studied in detail how messages of inflammatory cells are transmitted, on the basis of which they studied the method of inhibiting it.
Knowing the causes of inflammation will help in the treatment
Dr. Kannaganti, vice-president of the Department of Resistance Science at St. Jude Hospital, said, “Knowledge of how it works and the causes of inflammation is important in developing better treatment methods.”
It is noteworthy that Kenaganti was born and brought up in Telangana. He graduated from Chemistry, Zoology and Botany from Kakatiya University, Warangal. He received his Masters and PhD from Osmania University, India. In 2007, Dr. Kennagati joined St. Jude Hospital in Memphis, Tennessee State.
Kennagati said, “This research will increase our understanding.” We have identified the specific ‘cytokines’ (small proteins present in the cell that transmit) that cause inflammation in the cell and eventually lead to death. With this discovery, a possible cure for diseases of Kovid-19 and high mortality can be found. ”This research also includes Shraddha Tuladhar, Piramal Sameer, Min Zhenge, Balamurugan Sundaram, Balaji Bhanoth, RK Subbarao Malireddy etc.
Afghanistan will succeed only if terrorist activities are not conducted by ‘Durand Rekha’: India told UN
Covid Vaccine: 40 million doses of vaccine to be available in US by year-end – White House